Literature DB >> 9633754

Mood response to levodopa infusion in early Parkinson's disease.

R A Maricle1, R J Valentine, J Carter, J G Nutt.   

Abstract

Mood response to levodopa infusion was studied in 18 Parkinson's disease (PD) patients during the first year of levodopa therapy before and after 2-hour (1.0 mg/kg/h) levodopa infusions at baseline and 6- and 12-month follow-up. Mood elevation was greatest after a 2-day levodopa holiday at the 6- and 12-month assessments. Age, sex, duration and severity of PD, and ongoing oral levodopa dose did not correlate with mood response. Mood response in these patients differs from that seen in advanced patients, possibly because of sensitization to levodopa's mood effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9633754     DOI: 10.1212/wnl.50.6.1890

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Personality traits and brain dopaminergic function in Parkinson's disease.

Authors:  V Kaasinen; E Nurmi; J Bergman; O Eskola; O Solin; P Sonninen; J O Rinne
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

2.  Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat.

Authors:  Karen L Eskow Jaunarajs; Kristin B Dupre; Corinne Y Ostock; Thomas Button; Terrence Deak; Christopher Bishop
Journal:  Behav Pharmacol       Date:  2010-10       Impact factor: 2.293

Review 3.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

4.  Do neuropsychiatric fluctuations temporally match motor fluctuations in Parkinson's disease?

Authors:  Eleonora Del Prete; Emmanuelle Schmitt; Sara Meoni; Valerie Fraix; Anna Castrioto; Pierre Pelissier; Roberto Ceravolo; Elena Moro
Journal:  Neurol Sci       Date:  2022-01-19       Impact factor: 3.307

Review 5.  Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease.

Authors:  Hye Mi Lee; Seong-Beom Koh
Journal:  J Mov Disord       Date:  2015-05-31

Review 6.  The Human Experience with Intravenous Levodopa.

Authors:  Shan H Siddiqi; Natalia K Abraham; Christopher L Geiger; Morvarid Karimi; Joel S Perlmutter; Kevin J Black
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810

7.  Usability of the Experience Sampling Method in Parkinson's Disease on a Group and Individual Level.

Authors:  Anne E P Mulders; Rachel M J van der Velden; Marjan Drukker; Martijn P G Broen; Mark L Kuijf; Albert F G Leentjens
Journal:  Mov Disord       Date:  2020-05-30       Impact factor: 10.338

8.  COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor features.

Authors:  Angelo Antonini; Giovanni Abbruzzese; Paolo Barone; Ubaldo Bonuccelli; Leonardo Lopiano; Marco Onofrj; Mario Zappia; Aldo Quattrone
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.